{"id":"W4212971766","doi":"10.1002/jha2.394","title":"Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Princess Margaret Cancer Centre; University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Neutropenia; Rituximab; Lenalidomide; Internal medicine; Follicular lymphoma; Febrile neutropenia; Gastroenterology; Diffuse large B-cell lymphoma; Tolerability; Lymphoma; Refractory (planetary science); Adverse effect; Clinical endpoint; Phases of clinical research; Surgery; Chemotherapy; Clinical trial; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001001419,0.0008488909,0.001014124,0.00026714,0.0002580064,0.0006127846,0.0005832643,0.0006060625,0.001893882],"category_scores_gemma":[0.0005515025,0.0003786128,0.0004782804,0.0002935757,0.0004197551,0.0003881368,0.0001830506,0.001354505,0.0004602122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007365735,"about_ca_system_score_gemma":0.0009697839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001452041,"about_ca_topic_score_gemma":0.004435363,"domain_scores_codex":[0.9997805,0.000119438,0.00001131634,0.00002769258,0.00002323534,0.00003782774],"domain_scores_gemma":[0.999709,0.00003130807,0.00005080919,0.00001646848,0.00002415756,0.0001683188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4819241,0.1055885,0.02069992,0.001830577,0.002124876,0.0007517248,0.0006079522,0.003996121,0.1485507,0.0006136151,0.009383244,0.2239287],"study_design_scores_gemma":[0.4905778,0.475814,0.02031909,0.00006849976,0.0004809768,0.0005331301,0.0001348918,0.002054646,0.005102181,0.0001497611,0.004729137,0.00003603994],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940843,0.002162048,0.0002530101,0.0002060252,0.00006127635,0.001346703,0.0004325457,0.00005521457,0.001398896],"genre_scores_gemma":[0.9954748,0.001231349,0.0007101439,0.0003159659,0.00007730703,0.0007231593,0.0006702772,0.000008284343,0.000788816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001893882,"threshold_uncertainty_score":0.006335676,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00703040522547299,"score_gpt":0.2307756252306112,"score_spread":0.2237452200051382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}